Data Sheet 1_Emotional prompting amplifies disinformation generation in AI large language models.docx by Rasita Vinay (21006911)

“…Introduction<p>The emergence of artificial intelligence (AI) large language models (LLMs), which can produce text that closely resembles human-written content, presents both opportunities and risks. …”

Feasibility of AI-powered assessment scoring: Can large language models replace human raters? by Michael Jaworski III (22156096)

Percentage of ADR reports for PGx drugs and associated genes by decade. by Emma F. Magavern (20947928)

Subjects:

Quadratic inverse U-shape relationship between Moral Behavior during the pandemic and Instrumental Harm subscale. by Aistė Ambrasė (22505574)

Subjects:

Association between sociodemographic characteristics and reported safeguarding concerns in under 16 year olds with one or more alcohol-related attendance between 2011 and 2022. by Nicholas Davies (367476)

Subjects:

Correlations between OUS-DE, its subscales, moral dilemmas, and self-reported Utilitarianism. by Aistė Ambrasė (22505574)

Subjects:

Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene SLCO1B1 stratified by decade. by Emma F. Magavern (20947928)

Subjects:

Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2C19 stratified by decade. by Emma F. Magavern (20947928)

Subjects:

Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2D6 stratified by decade. by Emma F. Magavern (20947928)

Subjects:

ADR report numbers and patient demographics stratified by drug PGx status. Sex, age and severity comparison between pharmacogene actionable medicines and non pharmacogene actionabl... by Emma F. Magavern (20947928)

Subjects:

Alcohol-related attendances (n) and percentage of attendances resulting in admission between 2011 and 2022 (n = 812) for males and females. by Nicholas Davies (367476)

Subjects:

Association between sociodemographic characteristics and multiple alcohol-related attendances in under 16-year-olds with one or more alcohol-related attendance between 2011 and 202... by Nicholas Davies (367476)

Subjects:

Severity-related outcomes for male and female children with at least one alcohol-related attendance between 2011 and 2022 (n = 774). by Nicholas Davies (367476)

Subjects:

Annual alcohol-related attendance rates per 100,000 using mid-year population estimates for 5- to 15-year-olds in Merseyside (by gender). by Nicholas Davies (367476)

Subjects:

Association between sociodemographic characteristics and hospital admission in 5- 15 year olds with one or more alcohol-related attendance between 2011 and 2022. by Nicholas Davies (367476)

Subjects:

Demographic profile of children under the age of 16 (n = 774) with one or more alcohol-related attendance between 2011 and 2022, by sex. by Nicholas Davies (367476)

Subjects:

S1 File - by Kathleen Kristensen (17525457)

“…</p><p>Conclusions</p><p>The lack of perceived changes in harm reduction access by PWID and the decrease in those reporting difficulty accessing syringes as the pandemic progressed suggests the efficacy of adaptations to harm reduction service provision (e.g., window and mobile service) during the pandemic. …”

Chicago COVID-19 mitigation policy timeline. by Kathleen Kristensen (17525457)

“…</p><p>Conclusions</p><p>The lack of perceived changes in harm reduction access by PWID and the decrease in those reporting difficulty accessing syringes as the pandemic progressed suggests the efficacy of adaptations to harm reduction service provision (e.g., window and mobile service) during the pandemic. …”

Percentage of adverse drug reactions (ADRs) for pharmacogene-associated medications. by Emma F. Magavern (20947928)

Subjects:

Clinical Pharmacogenetics Implementation Consortium list of clinically actionable drugs with a pharmacogenomic indication and their associated genes. by Emma F. Magavern (20947928)

Subjects: